Table 1.
Baseline characteristics
| Characteristic | PCP (n = 90) | Non-PCP (n = 79) | p value |
|---|---|---|---|
| Age, yr | 55.3 ± 1.7 | 61.1 ± 1.9 | 0.020 |
| Male sex | 56 (62) | 52 (66) | 0.630 |
| Underlying disease | < 0.001 | ||
| Hematological malignancies | 38 (42) | 22 (28) | |
| Solid tumors | 27 (30) | 16 (20) | |
| Solid organ transplant recipients | 11 (12) | 3 (4) | |
| Autoimmune disease | 8 (9) | 10 (13) | |
| Othersa | 5 (6) | 26 (33) | |
| None | 1 (1) | 2 (2) | |
| Previous steroid treatment | 32 (36) | 18 (23) | 0.070 |
| Immunosuppressantsb | 34 (38) | 20 (25) | 0.080 |
| Chemotherapy within 1 month | 21 (23) | 11 (14) | 0.120 |
Values are presented as mean ± SEM or number (%).
PCP, Pneumocystis pneumonia.
a
Others include liver cirrhosis, pulmonary tuberculosis, end stage renal disease, interstitial lung disease, and chronic obstructive lung disease.
b
Immunosuppressants include cyclosporine, tacrolimus, and methotrexate.